Gum-Sized AI device could prevent deadly potassium spikes in kidney patients

NCT ID NCT06901960

Recruiting now Disease control Sponsor: Peking University First Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a small, AI-powered ECG device that looks like a stick of gum to help people with moderate-to-advanced chronic kidney disease monitor their potassium levels at home. Participants will use the device at least twice a week and receive alerts if levels are abnormal. The goal is to see if frequent monitoring reduces dangerous high potassium episodes over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-enhanced electrocardiogram device
What this could lead to: If successful, this device could help people with chronic kidney disease avoid dangerous high potassium levels by catching them early and prompting action.
What could go wrong: This is a relatively early-stage trial with 1066 participants, and the device's accuracy may vary in real-world use. It is not a treatment for kidney disease itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (STAGES 3B-5) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome Hyperkalemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE (STAGES 3B-5)

Contacts and locations

Locations

Hubei Provincial Hospital of TCM
NOT_YET_RECRUITING

Wuhan, Hubei, 430063, China
Peking University First Hospital
RECRUITING

Beijing, Beijing Municipality, 100034, China
The First Affiliated Hospital of Guangxi Medical University
NOT_YET_RECRUITING

Nanning, Guangxi, 530021, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.